Medigen says ready to produce vaccines next yearHUMAN TRIALS: Twenty million doses would be Medigen’s maximum production capacity and would be enough to inoculate 10 million people, the company saidBy Kao Shih-ching / Staff reporterMedigen Vaccine Biologics Corp (高端疫苗) yesterday said it would be ready to manufacture 20 million doses of its experimental COVID-19 vaccine next year if it gains emergency use authorization from the government by June. Twenty million doses would be enough to vaccinate 10 million people, as each person would need two doses, Lee said. Although the pandemic has been controlled in Taiwan, vaccines and drugs are deemed essential in fighting the disease. Some locally developed vaccine candidates, including those by Medigen, Adimmune Corp (國光生技) and United Biomedical Inc (聯亞生技), have undergone phase 1 human trials. Medigen has enrolled 45 participants aged 20 to 50 for its phase 1 trial in Taiwan.

Source: Taipei Times November 03, 2020 15:56 UTC